Trials / Completed
CompletedNCT04777643
Sex Differences in Neural Response to Cannabidiol
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, double-blind, within-subjects, cross-over design to assess neural changes following a single dose of cannabidiol (CBD) (600mg) versus placebo among healthy female volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabidiol | Participants will receive a single 600mg oral dose of Epidiolex (cannabidiol) 2 hours prior to fMRI scanning. |
| OTHER | Placebo | Participants will receive a single oral dose of placebo 2 hours prior to fMRI scanning. |
Timeline
- Start date
- 2022-06-07
- Primary completion
- 2023-04-27
- Completion
- 2023-04-27
- First posted
- 2021-03-02
- Last updated
- 2023-12-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04777643. Inclusion in this directory is not an endorsement.